Fresenius Medical Care AG (FMS)
FMS trades on NYSE in Health Care, Misc Health and Biotechnology Services. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC 20-F (ifrs-full:Revenue), period ending 2025-12-31, https://www.sec.gov/Archives/edgar/data/1333141/000110465926019005/0001104659-26-019005-index.htm. Net income: SEC 20-F (ifrs-full:ProfitLossAttributableToOwnersOfParent), period ending 2025-12-31. Converted from EUR at 0.8933 per USD (ECB reference rate).
Profile
| Field | Value |
|---|---|
| Ticker | FMS on NYSE |
| Sector | Health Care |
| Industry | Misc Health and Biotechnology Services |
| Country | Germany |
| IPO year | Not reported by the screener |
| SEC CIK | 0001333141 |
| SEC industry code | Services-Misc Health & Allied Services, NEC |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $22.0B |
| Net income | $1.1B |
| Operating income | Not in SEC XBRL data |
| Net margin | 5.0% |
| Operating margin | Operating income not reported |
| Revenue growth | No prior-year revenue to compare |
| Cash | Not in SEC XBRL data |
| Total assets | Not in SEC XBRL data |
| P/E (computed) | 10.8× |
| P/S (computed) | 0.5× |
Reported in EUR; shown in US dollars.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B3 | 2023-06-06 |
| Latest annual report FORM 20-F | 20-F | 2026-02-24 |
| Latest quarterly / interim FORM 6-K | 6-K | 2026-10-07 |
Source: SEC EDGAR submissions feed, 598 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | +4.1% |
| 1 month | -6.2% |
| 3 months | -10.6% |
| Year to date | -9.6% |
| 1 year | -21.4% |
| From 52-week high | -21.4% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Misc Health and Biotechnology Services
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| DVA | DaVita Inc. | $182.08 | +0.17% | $11.6B |
| SHC | Sotera Health Company | $18.21 | +0.33% | $5.2B |
| PGNY | Progyny Inc. | $27.39 | -2.28% | $2.1B |
| AGL | agilon health inc. | $85.90 | +0.48% | $1.4B |
| VMD | Viemed Healthcare Inc. Common Shares | $9.61 | +0.10% | $366.0M |
| PARK | Park Dental Partners Inc. | $19.59 | -3.31% | $93.2M |
| CCEL | Cryo-Cell International Inc. | $4.30 | -4.44% | $34.7M |
| MGRX | Mangoceuticals Inc. | $0.3716 | -3.08% | $8.3M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier